Recent Finacing
Recent Raise
Syntarga B.V., a Radboud University Nijmegen spin-off based in Nijmegen, develops linker technology for constructing antibody-drug conjugates (ADCs) to attach cytotoxic payloads to antibodies.
Focus Areas
Recent Investors
Funding round
Investor